Evaluation of the Physician Education Component of the Ozurdex Risk Management Plan

Study type

• Study topic:
  Human medicinal product
• Study type:
  Non-interventional study
• Scope of the study:
  Effectiveness study (incl. comparative)
• Data collection methods:
  Primary data collection

Non-interventional study

• Non-interventional study design:
  Cross-sectional

  Other
• Non-interventional study design, other:
  Online survey

Study drug and medical condition

• Name of medicine:
  OZURDEX

Population studied

• Short description of the study population:
  Physicians (ophthalmologists and retinal specialists) in France, Germany, Spain, and the UK who have administered an Ozurdex injection to at least one patient in the past 6 months.
• Age groups:
  Adults (18 to < 46 years)

  Adults (46 to < 65 years)

  Adults (65 to < 75 years)

  Adults (75 to < 85 years)

  Adults (85 years and over)
• Estimated number of subjects:
  400

Study design details

• Main study objective:
  The objective of this survey is to assess the effectiveness of the educational material provided to physicians treating patients with Ozurdex by evaluating the physicians’ knowledge and understanding of the key
• Outcomes:
  the goal of the survey is to evaluate the physicians’ knowledge and understanding of the key information in the Ozurdex Injector’s Guide
• Data analysis plan:
  The analyses will be descriptive in nature and will include a detailed review of responses to individual questions, as well as potential summary measure across logical groupings of response items.

Documents

Study results

Ozurdex RMM Eval_final study report Abstract